PAI Life Sciences Doses First Healthy Volunteer in Schistosomaisis Vaccine Clinical Trial

•
May 31, 2022

PRESS RELEASE Deadly topical disease threatens hundreds of millions worldwide. SEATTLE–  May 31, 2022 –PAI Life Sciences, a biotechnology company specializing in translational research for neglected tropical diseases, today announced

Read More »

GeekWire: Seattle Biotech Started by Gates Foundation Launches Trial for Snail Fever Vaccine

•
May 31, 2022

Read More »